Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

CRISPR Therapeutics AG - Common Shares (NQ: CRSP )

52.22 +2.50 (+5.03%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 18, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about CRISPR Therapeutics AG - Common Shares

< Previous 1 2 3 4 5 6 7 8 9
...
31 32 Next >
The 3 Best Gene Editing Stocks to Buy in July 2024
Gene editing is revolutionizing medicine, creating substantial opportunities for some of the best gene editing stocks. 
Via InvestorPlace
3 Pharma Stocks Already Ushering in the Next Biotech Boom
So long as diseases afflict the human condition, there will likely always be a need for pharma stocks. Here are three to consider. 
Via InvestorPlace
3 Top-Rated Gene Editing Stocks Actually Making Money
Profitable gene editing stocks make increasingly compelling investments as therapies commercialize this year and beyond. 
Via InvestorPlace
Trading SMID Biotech Stocks In A Volatile Market
Trading SMID biotech stocks is difficult no matter what you know. Large cap biopharma with dividends should be the focus for non-traders. Healthcare and smaller caps are lagging within the context of a... 
Via Talk Markets
You’ve Been Warned! 3 Gene Editing Stocks to Buy Now or Regret Forever.
The best gene editing stocks to buy are those with strong tehnogical applications and genuine commercialization prospects. 
Via InvestorPlace
3 Reasons to Buy CRISPR Therapeutics Stock Like There's No Tomorrow
There are a handful of different factors that could buoy its stock. 
Via The Motley Fool
Is CRISPR Therapeutics a Millionaire Maker?
The stars are aligning for it to be a leader for years to come. 
Via The Motley Fool
Is CRISPR Therapeutics Stock a Buy?
The gene-editing therapy specialist is rising in prominence. 
Via The Motley Fool
Rags to Riches: 3 Biotech Stocks That Could Make Early Investors Rich
These three biotech stocks to buy carry risks but may appeal to speculative investors with time and patience. 
Via InvestorPlace
You’ve Been Warned! 3 Biotech Stocks to Buy Now or Regret Forever.
Invest in the top biotech stocks to buy, as the sector pivots from pandemic-driven vaccine sales to solutions for chronic conditions. 
Via InvestorPlace
Is CRISPR Therapeutics Stock a Buy? One Analyst Thinks the Biotech Is "Very Undervalued."
The biotech's shares have traded sideways for over a year, but better days could be on the near-term horizon. 
Via The Motley Fool
3 Biotech Stocks That Could Make Your Grandchildren Rich
These biotech stocks are poised to generate significant returns to investors due to their high growth potential. 
Via InvestorPlace
Rags to Riches: 3 Gene Editing Stocks That Could Make Early Investors Rich
Gene editing is a game-changer, creating substantial opportunities for some of the leading gene editing stocks. 
Via InvestorPlace
3 Gene Editing Stocks That Could Make Your Grandchildren Rich
Explore gene-editing stocks with long-term growth potential, offering innovative solutions to previously untreatable conditions. 
Via InvestorPlace
The Next Big Thing After AI? 3 Sleeper Stocks to Buy Before the Boom
These three sleeper stocks could deliver massive gains if their cutting-edge technologies take off in the coming years. 
Via InvestorPlace
7 ‘FIRE’ Stocks to Put You on the Path to Financial Freedom
With so many young people eager to get out of the corporate rat race, these FIRE stocks can accelerate your path and stay free. 
Via InvestorPlace
Cathie Wood Goes Bargain Hunting: 2 Stocks She Just Bought
These companies could generate explosive growth over time. 
Via The Motley Fool
Cathie Wood Is Buying the Dip on These 2 Biotech Stocks. Should You?
In keeping with Cathie Wood's style, these picks are riskier than average. 
Via The Motley Fool
Cathie Wood Has Been Steadily Selling Shares of This Growth Stock. Should You?
Teladoc's share performance has reflected its earnings struggles... 
Via The Motley Fool
7 Stocks You Haven’t Heard of (That EVERYONE Should Own)
These under-the-radar must-own stocks across various sectors are using powerful megatrends and posting solid financial results. 
Via InvestorPlace
7 Biotech Stocks to Put on Your Breakthrough Radar
Although biotech stocks can present volatility risks due to its feast-or-famine nature, their narrative offers permanent relevance. 
Via InvestorPlace
The 2030 Millionaire’s Club: 3 Biotech Stocks to Buy Now
With interest cuts on the horizon, it's a prime time to consider these high-risk-high-reward biotech stocks to buy. 
Via InvestorPlace
7 Must-Buy Stocks if You Only Have $1,000 to Spend: May Edition
With a modest $1,000 investment, these stocks offer the potential for market-beating gains through solid fundamentals and growth prospects. 
Via InvestorPlace
Bull Market Buys: 2 Growth Stocks to Own for the Long Run
These biotech stocks have just launched their first products. 
Via The Motley Fool
Wall Street Favorites: 3 Biotech Stocks with Strong Buy Ratings for May 2024
With new innovation, millions of retiring baby boomers, and an increase in mergers, biotech stocks to buy have a good deal of upside ahead. 
Via InvestorPlace
7 No-Brainer Stocks to Buy and Hold for the Next 20 Years: May 2024
Here are seven stocks to buy and hold that are poised for long-term growth over the next 20 years and can future-proof your portfolio. 
Via InvestorPlace
Is CRISPR Stock Going to $95? 1 Wall Street Analyst Thinks So.
How much would you pay for a stock that might earn $25 a year in six years? 
Via The Motley Fool
2 Healthcare Stocks to Buy and Hold for Great Long-Term Potential
These healthcare stocks offer completely different approaches to long-term investment gains. 
Via The Motley Fool
The 3 Best Cathie Wood Stocks to Buy in May 2024
Cathie Wood takes a very risky approach to investing, but she has plenty of great picks. Here are some of the best Cathie Wood stocks to buy. 
Via InvestorPlace
The 3 Most Undervalued Biotech Stocks to Buy in May 2024
Three most undervalued biotech stocks to buy now will take off in the coming years and bring back continuous, hefty returns. 
Via InvestorPlace
< Previous 1 2 3 4 5 6 7 8 9
...
31 32 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.